Inhibition of the STAT3 Target SGK1 Sensitizes Diffuse Large B Cell Lymphoma Cells to AKT Inhibitors

Blood Cancer Journal - United States
doi 10.1038/s41408-019-0203-y
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Diffuse Large B-Cell Lymphoma

2020English

ALK -Positive Diffuse Large B-Cell Lymphoma

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2011English

The Genetic Landscape of Diffuse Large B-Cell Lymphoma

Seminars in Hematology
Hematology
2015English

Primary Diffuse Large B-Cell Lymphoma of the Mandible

Autopsy and Case Reports
2019English

B-Cell Receptor Signaling in Diffuse Large B-Cell Lymphoma

Seminars in Hematology
Hematology
2015English

Molecular Pathogenesis of Diffuse Large B-Cell Lymphoma

Seminars in Diagnostic Pathology
Forensic MedicinePathology
2011English

The Molecular Biology of Diffuse Large B-Cell Lymphoma

Therapeutic Advances in Hematology
Hematology
2011English

Identification of ADGRE5 as Discriminating MYC Target Between Burkitt Lymphoma and Diffuse Large B-Cell Lymphoma

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Primary Diffuse Large B-Cell Lymphoma of the Bladder

Internal Medicine
Internal MedicineMedicine
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy